Articles

Results 6 to 10 of 13


Australian High Court rule on obviousness - the Rosuvastatin (CRESTOR) decision

Australia - September 3 2015 The High Court on 2 September 2015 handed down its decision in the appeal by AstraZeneca against a finding of the Full Federal Court that the claims…

Patentability of nucleic acid molecules - on its way to the High Court

Australia - February 17 2015 The Australian High Court has allowed an application for special leave from the Appeal Court (Full Federal Court) decision in D'Arcy v Myriad…

Myriad in wonderland: under Alice, diagnostic method claims dealt another blow in the United States

USA - January 8 2015 Just when it seemed the US Patent Office (USPTO) had relaxed its assessment of patent eligibility for certain types of subject matter relating to…

Ken Seidenman

New interim guidance on patent subject matter eligibility…something markedly different!?

USA - December 17 2014 After some delay, the US Patent Office (USPTO) has now released its 2014 Interim Guidance on Patent Subject Matter Eligibility, a copy of which can…

Ken Seidenman

Update on Australian Federal Court decision regarding patentability of isolated nucleic acid molecules

Australia - September 19 2014 On Tuesday 16th September, an application for special leave to appeal to the High Court was made on behalf of Yvonne D'Arcy, the appellant in the…